Zurich, Switzerland

Susan Margaret De Paul

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Lexicon Pharmaceuticals, Inc., Intrexon Corporation, Gruenenthal Gmbh. Active years: 2011-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susan Margaret De Paul. Retrieved from https://idiyas.com/inventor/susan-margaret-de-paul

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9 

% Patents Active = 77.8

 

 

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Zurich, CH (2011)
  • Zürich, CH (2012 - 2019)

Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Susan Margaret De Paul: Innovator in Crystalline Diacylhydrazine

Introduction: Susan Margaret De Paul is a distinguished inventor based in Zurich, Switzerland. She holds an impressive portfolio with a total of nine patents to her name. Her groundbreaking work primarily revolves around the field of pharmaceuticals, particularly in the development of crystalline diacylhydrazine compounds.

Latest Patents: Among her notable contributions, her latest patents focus on crystalline polymorphic and amorphous forms of specific hydrazide compounds. These include (R)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N'-(2-ethyl-3-methoxy-benzoyl)-hydrazide (Compound 1) and (S)-3,5-dimethyl-benzoic acid N-(1-tert-butyl-butyl)-N'-(2-ethyl-3-methoxy-benzoyl)-hydrazide (Compound 2). Her disclosures provide detailed methodologies for making and utilizing these compounds, emphasizing their applications in regulating gene expression in various biological contexts.

Career Highlights: Susan's career has been enriched by her contributions to leading companies in the pharmaceutical industry, notably Lexicon Pharmaceuticals, Inc. and Intrexon Corporation. Her expertise has led to significant advancements in the utilization of diacylhydrazine compounds in medical applications.

Collaborations: Throughout her career, Susan has collaborated with esteemed colleagues, including Anett Perlberg and Robert Eugene Hormann. These partnerships have fostered an environment conducive to innovation and research development.

Conclusion: Susan Margaret De Paul stands out as a pivotal inventor in the realm of crystalline diacylhydrazine compounds. Her achievements underscore the significance of her work in advancing pharmaceutical research, particularly in gene expression regulation. With her nine patents, she continues to inspire future innovations in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…